Compile Data Set for Download or QSAR
Report error Found 55 Enz. Inhib. hit(s) with all data for entry = 50001250
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273535(CHEMBL4130288 | US11535607, Example 18-1)
Affinity DataIC50: 1nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273522(CHEMBL4127743 | US11535607, Example 12-1)
Affinity DataIC50: 2nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273525(CHEMBL4128972 | US11535607, Example 18-2)
Affinity DataIC50: 2nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273553(CHEMBL4127020 | US10508088, ID HDTK028 | US1153560...)
Affinity DataIC50: 2nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 6(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273537(CHEMBL4128164 | US11535607, Example 50-5)
Affinity DataIC50: 2nMAssay Description:Inhibition of full length recombinant human HDAC6 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273520(CHEMBL4127735 | US11535607, Example 22-3)
Affinity DataIC50: 3nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
Affinity DataIC50: 3nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 6(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273524(CHEMBL4129402 | US11535607, Example 50-4)
Affinity DataIC50: 4nMAssay Description:Inhibition of full length recombinant human HDAC6 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273538(CHEMBL4127894 | US11535607, Example 22-6)
Affinity DataIC50: 5nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273554(CHEMBL4129134 | US11535607, Example 22-2)
Affinity DataIC50: 6nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273551(CHEMBL4129143 | US11535607, Example 45-1)
Affinity DataIC50: 7nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273549(CHEMBL4129266 | US11535607, Example 15-1)
Affinity DataIC50: 7nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273520(CHEMBL4127735 | US11535607, Example 22-3)
Affinity DataIC50: 12nMAssay Description:Inhibition of NanoLuc-tagged HDAC11 (unknown origin) by BRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
Affinity DataIC50: 15nMAssay Description:Inhibition of NanoLuc-tagged HDAC11 (unknown origin) by BRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273525(CHEMBL4128972 | US11535607, Example 18-2)
Affinity DataIC50: 20nMAssay Description:Inhibition of NanoLuc-tagged HDAC11 (unknown origin) by BRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273523(CHEMBL4129231 | US11535607, Example 7-2)
Affinity DataIC50: 26nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273536(CHEMBL4126502 | US11535607, Example 22-7)
Affinity DataIC50: 27nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273521(CHEMBL4129070 | US11535607, Example 50-3)
Affinity DataIC50: 30nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273550(CHEMBL4125954 | US11535607, Example 7-4)
Affinity DataIC50: 35nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 6(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273539(CHEMBL4125815 | US11535607, Example 50-6)
Affinity DataIC50: 82nMAssay Description:Inhibition of full length recombinant human HDAC6 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273538(CHEMBL4127894 | US11535607, Example 22-6)
Affinity DataIC50: 85nMAssay Description:Inhibition of NanoLuc-tagged HDAC11 (unknown origin) by BRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273554(CHEMBL4129134 | US11535607, Example 22-2)
Affinity DataIC50: 130nMAssay Description:Inhibition of NanoLuc-tagged HDAC11 (unknown origin) by BRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273540(CHEMBL4127193 | US11535607, Example 1-6)
Affinity DataIC50: 170nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273536(CHEMBL4126502 | US11535607, Example 22-7)
Affinity DataIC50: 270nMAssay Description:Inhibition of NanoLuc-tagged HDAC11 (unknown origin) by BRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273552(CHEMBL4125788)
Affinity DataIC50: 300nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273533(CHEMBL4126784 | US11535607, Example 50-2)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273524(CHEMBL4129402 | US11535607, Example 50-4)
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273534(CHEMBL4127829 | US11535607, Example 1-2)
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 6(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273521(CHEMBL4129070 | US11535607, Example 50-3)
Affinity DataIC50: 2.80E+3nMAssay Description:Inhibition of full length recombinant human HDAC6 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273539(CHEMBL4125815 | US11535607, Example 50-6)
Affinity DataIC50: 4.60E+3nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 8(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of full length recombinant human HDAC8 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 1(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC1 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 1(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273519(CHEMBL4129930)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC1 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 6(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273519(CHEMBL4129930)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC6 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 6(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC6 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetPolyamine deacetylase HDAC10(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273519(CHEMBL4129930)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC10 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 9(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC9 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 9(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273519(CHEMBL4129930)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC9 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 7(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC7 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 5(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC5 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 4(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273519(CHEMBL4129930)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC4 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 3(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273519(CHEMBL4129930)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC3 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 2(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC2 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 11(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273537(CHEMBL4128164 | US11535607, Example 50-5)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC11 expressed in baculoviral expression system using FAM-RHKK as substrate by electrophoretic mobility...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 7(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273519(CHEMBL4129930)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC7 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 4(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273526(CHEMBL4126661 | US11535607, Example 22-8)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC4 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 2(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273519(CHEMBL4129930)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC2 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 5(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273519(CHEMBL4129930)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC5 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 6(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273540(CHEMBL4127193 | US11535607, Example 1-6)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC6 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
TargetHistone deacetylase 6(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50273533(CHEMBL4126784 | US11535607, Example 50-2)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human HDAC6 using fluorescent-labeled peptide as substrate by electrophoretic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2020
Entry Details Article
PubMed
Displayed 1 to 50 (of 55 total ) | Next | Last >>
Jump to: